We develop computational topological bioinformatics software for biomedical and biotechnology industry professionals to program, scale, and optimize big data.
We started in January 2016, completed a beta test in March 2016, and launched an experimental alpha validation test in Mid-March 2016. We are consulting with labs, leaders and professionals within the biotech, biomedical, and physical industries. We anticipate selling core technology or subscription licensing in 2016. Astroid is a bootstrap company expecting U.S. $500,000 in 2016, and dramatically increasing to 25 million per year by 2020.